Medidata Insights on Clinical Trial Enrollment White Paper
Medidata Insights on Clinical Trial Enrollment
As the pandemic continues to fluctuate, we look back at 2021 to assess the continued impact of the pandemic on clinical trial enrollment to help the industry navigate the dynamic landscape as we enter 2022. This report highlights granular trial enrollment insights across therapeutic areas (oncology, immunomodulation, central nervous system (CNS), and cardiovascular) and geographic regions (North America, Europe, Asia).
Read our white paper to explore key findings and global insights on clinical trial enrollment and how it could impact your trial:
- Global Enrollment Trend During the COVID-19 Pandemic
- Enrollment Trends Broken Down by Therapeutic Area
- Enrollment recovery among countries
Utilizes historical performance metrics from 28,000+ clinical trials with granularity at the study, country, and site level and associated investigators. Provides site ranking based on predictive enrollment models for 130+ indications. Our own proprietary congestion metrics.
Let’s talk. Connect to discuss how to leverage the largest industry scientific and operational dataset to power your site selection and enrollment.
Explore more resources and talk to our solution consultants now!